Back to search

United Kingdom· GB-APID-14682311000001103

Bio-CLA 500mg capsules

A medicinal product containing safflower oil, refined, registered in United Kingdom by Pharma Nord (UK) Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedBio-CLA 500mg capsulesATC—REGISTER NO.GB-APID-1468231100000…PACKS LISTED3CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Safflower oil, refined
Manufacturer
Pharma Nord (UK) Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 3

  • gtin
    5709976075207
  • gtin
    5709776075506
  • gtin
    5709976075504

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c2bebd1d-f894-4372-9a3c-ecb076f80d4a
GET /v1/drugs/c2bebd1d-f894-4372-9a3c-ecb076f80d4a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "14682311000001103",
  "desc": "Bio-CLA 500mg capsules (Pharma Nord (UK) Ltd)",
  "form": "Oral capsule",
  "vpid": "14683311000001108",
  "source": "dmd",
  "vtm_id": null,
  "strength": "500 mg",
  "substance": null,
  "ingredient": "Safflower oil, refined",
  "supplier_code": "2082501000001109"
}

See everything about safflower oil, refined.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.